Impulse control disorders in Parkinson's disease: definition, epidemiology, risk factors, neurobiology and management

https://doi.org/10.1016/S1353-8020(09)70847-8 Get rights and content

Abstract

There is increasing awareness that impulse control disorders (ICDs), including pathological gambling, hyper-sexuality, compulsive eating and buying, can occur as a complication of Parkinson's disease (PD). In addition, other impulsive or compulsive disorders have been reported to occur, including dopamine dysregulation syndrome (DDS) and punding. Case reports and prospective studies have reported an association between ICDs and the use of dopamine receptor agonists at higher doses, and DDS has been associated with l-dopa at higher doses or short-acting dopamine receptor agonists. Risk factors for ICDs include male sex, younger age or younger age at PD onset, a pre-PD history of ICD symptoms, history of substance use or bipolar disorder, and a personality profile characterized by impulsiveness. The management of clinically significant ICD symptoms should consist of modifications to dopamine replacement therapy, particularly dopamine receptor agonists, which is usually associated with an improvement of ICDs. There is no empirical evidence supporting the use of psychiatric drugs for ICDs in PD. Functional neuroimaging studies such as functional MRI and PET can investigate in vivo the neurobiological basis of these pathological behaviours.

Introduction

Impulse control disorders (ICDs) are characterized by the failure to resist an impulse, drive or temptation to perform an act that is harmful to the person or to others. It is very important to recognize ICDs because they can cause considerable distress to patients and caregivers, and can have disastrous personal, financial and socio-familial consequences. They are certainly underreported due to patients' embarrassment to admit to having them.

The formal ICDs are grouped together in a category entitled “ICDs not elsewhere classified” and include intermittent explosive disorder, kleptomania, pyromania, pathological gambling (PG), trichotillomania, and ICD not otherwise specified (ICD-NOS). Different psychiatric disorders characterized by impaired impulse control (e.g. bipolar disorders, binge-eating disorder, and attention-deficit hyperactivity disorder) are classified elsewhere in the DSM. ICD-NOS includes compulsive sexual behaviours, compulsive buying or shopping, problematic internet use, and compulsive skin picking [1]. Other psychiatric disorders or behaviours that share features of ICDs have been reported to occur in Parkinson's disease (PD) in the context of dopamine replacement therapy (DRT). For instance, with excessive use of DRT, patients have been reported to develop (hypo)mania, a mood disorder that can imply excessive involvement in pleasurable activities that have a high potential for painful consequences. In addition, obsessive–compulsive disorder, an anxiety disorder characterized by the repetition of nonharmful behaviours to reduce anxiety, may occur at an increased frequency in PD, although it has not been reported in association with DRT. Punding and walkabout are characterized by repetitive behaviours and poor impulse control, but the behaviours are typically nonpleasurable or low in risk–reward characteristics when compared with ICD behaviours [2]. Thus, ICDs may represent the severe end of a spectrum of behavioural disturbances in PD that are characterized by poorly or uncontrolled repetitive behaviours [3]. Another compulsive disturbance is represented by the dopamine dysregulation syndrome (DDS), which is characterized by the use of dopaminergic drugs in doses excessive to those required to treat motor symptoms despite the development of disabling dyskinesias [4]. The clinical characteristics of these patients meet accepted criteria for addiction: compulsive drug taking in excess of clinical requirements; intoxication similar to that seen with drugs such as cocaine and characterized by hypomania and impulsivity; persistent use despite social and personal difficulties caused by the drugs; withdrawal symptoms such as dysphoria and anxiety following dosage reductions; and hoarding the drug or obtaining prescriptions from different physicians.

The core features of ICDs include repetitive or compulsive engagement in a behaviour despite adverse consequences, diminished control over the problematic behaviour, an appetitive urge or craving state prior to engagement in the problematic behaviour, and a hedonic quality during the performance of the problematic behaviour. ICDs share a conceptual resemblance to drug addiction in that individuals pursue an activity in a compulsive manner despite harmful consequences, in particular the development of tolerance, the negative effect of withdrawal, repeated unsuccessful attempts to cut back or stop, and finally impairment in major areas of life functioning [5, 6, 7, 8].

Section snippets

Epidemiology of ICDs in PD

Following anecdotal reports of ICDs in PD patients treated with dopamine receptor agonists, studies were conducted in recent years to ascertain the prevalence of ICDs in the PD population. The prevalence rates reported are quite variable, ranging from 6% to 25%, and this heterogeneity might be due to methodological differences such as the measures used for screening [9, 10, 11, 12, 13, 14, 15, 16, 17, 18]. Nevertheless, even considering just the lowest prevalence rate reported, this rate is

Risk factors

Patients with PD who develop ICDs (especially PG) are usually male, have younger age at PD onset and therefore probably a drug prescribing pattern in favour of dopamine receptor agonists, have a personal or immediate family history of alcohol use disorders, or a prior history of ICD [25, 26, 27, 28, 29, 30]. In addition, the psychological profile may have a role as a risk factor since PD patients with ICDs have higher novelty-seeking trait scores, as well as impaired planning on an impulsivity

Neurobiology of ICDs in PD patients

The pathophysiology of ICDs has been reported to involve specific neurotransmitter systems, brain regions and neural circuitries. The crucial neural network appears to be the cortico-striatothalamo-cortical pathway and, with regard to the neurotransmitter dopamine system, seems to be critical mainly within the mesocorticolimbic pathway for reward and reinforcement processes. The brain areas mostly involved include the prefrontal cortex, mainly ventromedial and orbitofrontal areas, which are

Management

Management of ICDs consists of patient and caregiver education, modification of DRT, and, in some cases, psychoactive drugs. It is essential to identify individuals with active ICDs by an active screening. Clinicians should discuss current understanding of the risks and benefits of and alternatives to drug treatment, and they should highlight the importance of honest reporting. They should always involve the spouse or other family members and ensure medical compliance, including guarding

Conclusions

Current estimates suggest that ICDs are exhibited by approximately 10–14% of patients with PD. ICDs typically identified in PD fall into the domains of gambling, sex, shopping and eating. Risk factors for ICDs in PD include young age, impulsive or novelty-seeking personality, personal or family history of alcoholism, prior history of ICDs, and dopamine receptor agonist therapy. The role of genetic predisposition should be investigated to optimize prevention.

ICDs can be challenging to recognize

Conflict of interest

Roberto Ceravolo, Daniela Frosini and Carlo Rossi have nothing to declare. Ubaldo Bonuccelli has received consulting/lecture fees from GlaxoSmithKline, Novartis, Boehringer Ingelheim, Eli Lilly and Teva.

References (50)

  • E Hollander et al.

    Is compulsive buying a real disorder, and is it really compulsive?

    Am J Psychiatry

    (2006)
  • E Driver-Dunckley et al.

    Pathological gambling associated with dopamine agonist therapy in Parkinson's disease

    Neurology

    (2003)
  • C Lu et al.

    Gambling and Parkinson disease

    Arch Neurol

    (2006)
  • KA Grosset et al.

    Problematic gambling on dopamine agonists: not such a rarity

    Mov Disord

    (2006)
  • V Voon et al.

    Prospective prevalence of pathological gambling and medication association in Parkinson disease

    Neurology

    (2006)
  • D Weintraub et al.

    Association of dopamine agonist use with impulse control disorders in Parkinson disease

    Arch Neurol

    (2006)
  • V Voon et al.

    Prevalence of repetitive and reward-seeking behaviors in Parkinson disease

    Neurology

    (2006)
  • IU Isaias et al.

    The relationship between impulsivity and impulse control disorders in Parkinson's disease

    Mov Disord

    (2008)
  • GA Christenson et al.

    Compulsive buying: descriptive characteristics and psychiatric comorbidity

    J Clin Psychiatry

    (1994)
  • D Crockford et al.

    Prevalence of problem and pathological gambling in Parkinson's disease

    J Gambl Stud

    (2008)
  • M Avanzi et al.

    Prevalence of pathological gambling in patients with Parkinson's disease

    Mov Disord

    (2006)
  • R Ceravolo et al.

    Prevalence of impulse control disorders in Parkinson's disease

    Neurol Sci

    (2009)
  • HP Vogel et al.

    Hypersexuality–a complication of dopaminergic therapy in Parkinson's disease

    Pharmacopsychiatria

    (1983)
  • NS Harvey

    Serial cognitive profiles in levodopa-induced hypersexuality

    Br J Psychiatry

    (1988)
  • RJ Uitti et al.

    Hypersexuality with antiparkinsonian therapy

    Clin Neuropharmacol

    (1989)
  • Cited by (108)

    • Nanotechnology-based drug delivery systems for herbal medicine

      2023, Nanotechnology in Herbal Medicine: Applications and Innovations
    • The pathophysiology of sexual dysfunction in Parkinson's disease: An overview

      2022, International Review of Neurobiology
      Citation Excerpt :

      These, as suggested by Weintraub and Nirenberg (2013), are: the ventromedial and orbitofrontal prefrontal cortex, involved in planning and judgment, the ventral striatum (particularly the nucleus accumbens), core structure of the reward system, and the amygdala, which is involved in conditioned responses and emotional processing. In addition, while the ventral striatum seems to be more involved in the urgency and impulsivity aspects of ICD, the dorsal striatum might be more responsible of the compulsivity component of the disorder (Ceravolo, Frosini, Rossi, & Bonuccelli, 2009; Steeves, Miyasaki, Zurowski, et al., 2009). Hypersexuality in PD has been considered a manifestation of disinhibitory psychopathology due to failure of executive function in inhibiting reinforcing responses (Bhattacharyya & Rosa-Grilo, 2017; Codling, Shaw, & David, 2015), thus reflecting a dysfunction of the frontal lobes.

    • Prevalence, clinical presentations and impact on relationship

      2022, International Review of Neurobiology
      Citation Excerpt :

      Dopaminergic replacement therapy on the one hand should facilitate physical sexual activities and levodopa has been found to increase libido (Uitti et al., 1989). On the other hand dopaminergics, especially dopamine agonists, male gender (Weintraub, Koester, et al., 2010), younger age (< 60 years), early onset of PD and a history of behavioral problems (Nakum & Cavanna, 2016) as well as a personality with novelty seeking and a family and/or past history of addictive behavior (Ceravolo, Frosini, Rossi, & Bonuccelli, 2009) have been found as risk factors for ICD in general and CSB in particular. Studies indicate that CSB symptom severity is higher in men than in women in the normal population (Kowalewska, Gola, Kraus, & Lew-Starowicz, 2020) and in PD (El Otmani et al., 2019).

    • Management strategies of sexual dysfunctions in Parkinson's disease

      2022, International Review of Neurobiology
    View all citing articles on Scopus
    View full text